Welcome guest writer, Jantzen Cole, Vice President of Market Development, Extremities, Kuros Biosciences and a member of the OTW Industry Advisory Board
It’s time to say out loud: osteobiologics has been coasting for a decade. Not failing — coasting. And in a field that prides itself on innovation, coasting is its own kind of failure.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
